To this day, Covid-19 continues to spread around the world, leaving us unable to return to our daily lives as before. Along with the Covid-19 vaccine, US pharmaceutical company MERCK is now producing Molnupiravir Covid-19, which many countries around the world ordered to treat Covid-19 in an emergency.
1. What is the Molnupiravir supplement?
Molnupiravir Covid-19 is developed by scientists at Emory University in Georgia, USA. Prevent hospitalization, reduce the risk of death and prevent the new mutation of the Covid-19 virus.
2. How does Molnupiravir work?
Molnupiravir is used after patients with Covid-19 infection and symptoms. In clinical trials, the drug was given to study participants in 4 tablets and taken twice daily. Five days from the date of the first symptoms of Covid-19.
"Once a patient takes the drug, it enters the bloodstream and stops the ability of SARS-CoV-2 to transmit the virus." This is according to Dr. Albert Shaw, an infectious disease specialist at Yale Medicine.
3. Do Molnupiravir tablets have side effects?
According to data released by the pharmaceutical company MERCK, Molnupiravir tablets are safe and have no serious side effects in clinical trial volunteers.
Molnupiravir works by acting on RNA genes that interfere with infection, so there may be side effects that vary slightly from patient to patient. By their DNA or RNA. According to Merck, data from studies at the Molnupiravir laboratory did not cause any adverse changes in the body.
4. Which group of people can take Molnupiravir?
MERCK says its supplements work for high-risk adults. In clinical trials, most Molnupiravir tablets were given to people over 60 years of age or younger. However, there is a higher risk of the Covid-19 viruses, such as diabetes, heart disease, or obesity, and only individuals whose vaccines have not yet been included in the trial.
In addition, pregnant women infected with Covid-19 have not been able to take Molnupiravir because clinical trials were not included. Incorporate pregnant women into it, as it is not yet known whether it can affect the growth of the fetus after use or not.
5. If Molnupiravir is allowed, do we still need the vaccine?
Although Molnupiravir is effective in treating both Covid-19 and normal viral infections, experts say the Covid-19 vaccine is still effective. It is also an important way to prevent the spread of this deadly respiratory disease. People who are fully vaccinated have a lower risk of serious illness, hospitalization, and reduced risk of dying from the Covid-19 virus.